Anika to Participate in Upcoming Virtual Investor Conferences
September 03 2020 - 2:34PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint
preservation, restoration and regenerative solutions company with
products across the orthopedic early intervention continuum of
care, today announced that Cheryl R. Blanchard, Ph.D., President
and Chief Executive Officer, and Michael Levitz, Chief Financial
Officer, will participate in the following four virtual investor
conferences in September:
- Barrington Research Fall Investment Conference on Wednesday,
September 9, 2020. Dr. Blanchard and Mr. Levitz will participate in
virtual one-on-one meetings with investors.
- Wells Fargo Healthcare Conference on Thursday, September 10,
2020. Dr. Blanchard is scheduled to participate in a fireside chat
at 10:40 a.m. ET.
- Morgan Stanley Global Healthcare Conference on Thursday,
September 17, 2020. Dr. Blanchard is scheduled to participate in a
fireside chat at 8:45 a.m. ET.
- Sidoti Investor Conference on Thursday, September 24, 2020. Dr.
Blanchard is scheduled to present at 9:15 a.m. ET.
Live audio webcasts of the Wells Fargo, Morgan Stanley and
Sidoti presentations may be accessed via the "Investor Relations"
section of Anika’s website, www.anikatherapeutics.com. Audio
archives of the presentations also will be available on the
website.
About Anika Therapeutics, Inc. Anika
Therapeutics, Inc. (NASDAQ: ANIK), is a global, integrated joint
preservation, restoration and regenerative solutions company based
in Bedford, Massachusetts. Anika is committed to delivering
products along the orthopedic early intervention continuum of care
to improve the lives of patients, with a focus on osteoarthritis
pain management, sports medicine and joint preservation,
restoration and regeneration. The Company has close to three
decades of global expertise commercializing innovative products
across the orthopedic early intervention continuum of care. For
more information about Anika, please visit
www.anikatherapeutics.com.
For Investor Inquiries: Anika Therapeutics, Inc. Kristen Galfetti,
781-457-9000 Executive Director, Investor Relations
investorrelations@anikatherapeutics.com |
For Media Inquiries: W2O Group Rachel Girard, 617-379-6760
rgirard@w2ogroup.com |
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024